11 Best Stocks to Buy for the Next 3 Months According to Hedge Funds
On September 6, Rebecca Patterson, Chief Investment Strategist at Bridgewater Associates, appeared in an interview on CNBC to discuss the current US economy.
Summit Therapeutics Inc. (SMMT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lansdowne Partners Alex Snow | 0 | $0 | 0% | |
| 2. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 3. | Polar Capital Brian Ashford-Russell And Tim Woolley | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.07 | 5,000 | $90,350.00 | 556,093,090 | 2025-09-11 | Filing | |
| $17.68 | 333,394 | $5,894,405.92 | 556,088,090 | 2025-09-10 | Filing | |
| $18.07 | 5,000 | $90,350.00 | 556,093,090 | 2025-09-11 | Filing | |
| $17.68 | 333,394 | $5,894,405.92 | 556,088,090 | 2025-09-10 | Filing | |
| $3.71 | 20,000 | $74,200.00 | 50,000 | 2024-03-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.44 | 13,713 | $60,885.72 | 0 | 2020-11-30 | Filing | |
| $4.39 | 29,569 | $129,807.91 | 0 | 2020-11-27 | Filing | |
| $4.32 | 12,070 | $52,142.40 | 0 | 2020-11-25 | Filing | |
| $4.21 | 11,374 | $47,884.54 | 0 | 2020-11-24 | Filing | |
| $4.40 | 6,987 | $30,742.80 | 0 | 2020-11-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,042 | $43,454 | 0% | |
| 2. | 560 | $11,917 | 0% | |
| 3. | 501 | $10,661 | 0% | |
| 4. | 370 | $7,874 | 0% | |
| 5. | 187 | $3,979 | 0% |
News See All
H.C. Wainwright Lifts PT on Summit Therapeutics (SMMT) to $50 From $44
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best strong buy growth stocks to buy now. On August 27, H.C. Wainwright raised the firm’s price target on Summit Therapeutics Inc.
10 Best Strong Buy Growth Stocks to Buy Now
On August 27, Komal Sri-Kumar, Sri-Kumar Global Strategies president, appeared on CNBC’s ‘Squawk Box’ to talk about the fallout from President Trump’s firing of Fed Governor Lisa Cook, the effects...
Summit Therapeutics Advances as Trial Outcomes and New Collaboration Drive Optimism
[caption id="attachment_1220866" align="aligncenter" width="1456"] A laboratory employee in a sterile environment inspecting a microscope focused on a Clostridioides difficile infection sample.[/caption...
11 Best Short Squeeze Stocks to Buy Now
The latest U.S. tariff wave has created a suitable environment where short squeeze investments will thrive.
Summit Therapeutics (SMMT) Nosedives 9% on Dismal Earnings, Absence of Investor Call
Summit Therapeutics tumbled by 9.08 percent on Tuesday to close at $25.68 apiece as investor sentiment was dampened by a dismal earnings performance as well as the absence of an investor call to elaborate...
Summit Therapeutics (SMMT) Climbs 16% Ahead of Q2 Earnings
Summit Therapeutics surged by 16.05 percent on Wednesday to close at $28.27 apiece, leading the rally of the overall biotechnology sector, as investors repositioned portfolios ahead of the release of ...
Summit Therapeutics (SMMT) Jumps 7.6% on Reports of $15-Billion AstraZeneca Deal
[caption id="attachment_1220866" align="aligncenter" width="1456"] A laboratory employee in a sterile environment inspecting a microscope focused on a Clostridioides difficile infection sample.[/caption...
Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best hot stocks to buy according to Wall Street analysts.
Revolution Medicines, Summit Therapeutics Partner on RAS Inhibitor/Ivonescimab Combinations for Solid Tumors
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best high short interest stocks with huge upside potential. On June 30, Revolution Medicines and Summit Therapeutics Inc.
Hedge Fund Resource Center Billionaire Hedge Funds
